Soluble ST2 is a sensitive clinical marker of ulcerative colitis evolution
about
The ST2/IL-33 Axis in Immune Cells during Inflammatory Diseases.A functional IL1RL1 variant regulates corticosteroid-induced sST2 expression in ulcerative colitisRecent Advances: The Imbalance of Cytokines in the Pathogenesis of Inflammatory Bowel Disease.IL33-mediated ILC2 activation and neutrophil IL5 production in the lung response after severe trauma: A reverse translation study from a human cohort to a mouse trauma model.Differential production of interleukin-1 family cytokines (IL-1β, IL-18, IL-33 and IL-37) in patients with paracoccidioidomycosis: correlation with clinical form and antifungal therapy.
P2860
Soluble ST2 is a sensitive clinical marker of ulcerative colitis evolution
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Soluble ST2 is a sensitive clinical marker of ulcerative colitis evolution
@ast
Soluble ST2 is a sensitive clinical marker of ulcerative colitis evolution
@en
type
label
Soluble ST2 is a sensitive clinical marker of ulcerative colitis evolution
@ast
Soluble ST2 is a sensitive clinical marker of ulcerative colitis evolution
@en
prefLabel
Soluble ST2 is a sensitive clinical marker of ulcerative colitis evolution
@ast
Soluble ST2 is a sensitive clinical marker of ulcerative colitis evolution
@en
P2093
P2860
P1433
P1476
Soluble ST2 is a sensitive clinical marker of ulcerative colitis evolution
@en
P2093
Daniela Simian
David Díaz-Jiménez
Glauben Landskron
Janitza Fuentes
Karen Dubois-Camacho
Marcela A Hermoso
Marjorie De la Fuente
María Julieta González
Tamara Pérez
P2860
P2888
P356
10.1186/S12876-016-0520-6
P577
2016-08-26T00:00:00Z
P6179
1013439908